1. Project Overview & International Regulatory Compliance Framework
Our global GMP standard biomanufacturing facility build delivers full-turnkey, compliance-certified plant construction solutions tailored for international biopharmaceutical production, fully adhering to FDA cGMP, EMA Annex 1, PIC/S harmonized GMP and ICH Q8/Q9/Q10 global quality risk management and data integrity specifications. Covering greenfield full-plant construction, brownfield GMP standard upgrading, cleanroom implementation, sanitary system deployment and full-process CQV commissioning, our services support standardized industrial manufacturing of monoclonal antibodies, recombinant proteins, viral vectors and vaccines across global markets. Conventional facility construction projects often incur prevalent industry pain points including regionally limited standard execution, non-uniform sanitary construction quality, incomplete GMP zoning logic, unvalidated utility systems and audit-deficient project documentation. With globally unified construction specifications and standardized quality control systems, we deliver fully GMP-compliant, inspection-ready biomanufacturing facilities that meet cross-jurisdictional audit requirements for international biotech enterprises, global CMO operators and cross-border pharmaceutical industrial projects.
2. Core Construction Philosophy & Global GMP Implementation Advantages
Guided by risk-based global GMP standardization and quality-by-design implementation principles, our facility build integrates international regulatory baseline requirements and bioprocess operational characteristics into every construction procedure. All cleanroom classification, unidirectional personnel and material flow layout, HVAC pressure cascade mechanism, ASME BPE-grade sanitary piping and central CIP/SIP utility systems are constructed and verified based on product critical quality attributes (CQAs) and critical process parameters (CPPs). We enforce unified global construction workmanship standards, zero-dead-leg orbital welding specifications and ALCOA+ data integrity infrastructure deployment, eliminating regional construction differences and inherent compliance loopholes. Unlike localized construction teams that only meet domestic standards, our global GMP execution model ensures consistent facility compliance, operational reproducibility and long-term cross-border audit readiness, effectively reducing post-construction standard rectification costs and validating operational stability for global biomanufacturing production.
3. Four Core Global GMP Construction Modules & Standard Deliverables
Our complete global GMP standard facility build system consists of four synergistic full-lifecycle construction modules covering design, construction, integration and qualification: global-standard GMP design module, classified cleanroom & civil construction module, sanitary utility & system integration module, and international GMP qualification & documentation module. The global design module conducts multi-standard regulatory gap analysis, GMP-aligned master plant layout, BIM 3D optimized process zoning and P&ID schematic development, delivering URS and DQ documents compatible with US, EU and global emerging market standards. The civil construction module implements hierarchical cleanroom enclosure construction, airtightness reinforcement, classified environmental control and GMP-compliant surface finishing to meet international contamination control requirements. The system integration module completes standardized installation of WFI/PW distribution, HVAC clean air circulation, sterile transfer systems and automated process control platforms with full sanitary coverage. The qualification documentation module performs systematic FAT/SAT testing, full IQ/OQ/PQ validation and English-version audit dossier sorting. Standard deliverables include global GMP construction archives, system certification reports, validation packages and as-built technical documents.
4. Industrial Application & Long-Term Global Compliance Support
Our global GMP standard facility build services are widely applied in cross-border biomanufacturing campus construction, international commercial biologic production bases, global clinical pilot GMP platforms and multi-standard compliant CMO manufacturing facilities. All constructed facilities adopt modular and scalable GMP architecture, reserving flexible expansion and process intensification interfaces to adapt to iterative global regulatory updates and new biotherapeutic pipeline deployment. We provide full-lifecycle global technical support including cross-border construction supervision, GMP standard compliance verification, operational standard training, periodic facility performance assessment and long-term regulatory iteration adaptation. By implementing rigorous global GMP standardized construction, we help global biopharmaceutical clients build internationally recognized, stable and audit-ready biomanufacturing infrastructure, eliminate cross-market compliance barriers, and accelerate global registration and large-scale commercialization of innovative biopharmaceutical products.
